Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalized once-daily tacrolimus dosing in pediatric kidney transplant recipients
2021-006481-21Phase 4Active
- Sponsor
- Erasmus MC
- Start
- Aug 2022
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tacrolimus in Kidney allograft status (RTx), sponsored by Erasmus MC. Started Aug 2022; status: active.
02
Drugs
tacrolimus
03
Conditions
Kidney allograft status (RTx)
Beyond the preview
Go deeper on 2021-006481-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-006481-21.